FORT MILL, SC / ACCESSWIRE / December 5, 2023 / Catheter Precision, Inc. (NYSE American:VTAK) is pleased to announce that it has been invited to present at the Emerging Growth Conference on December 6, 2023. Catheter Precision, Inc. (NYSE American: VTAK) will be discussing VIVO™, its innovative non-invasive, 3D mapping system that enables physicians to identify the origin of ventricular cardiac arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO received marketing clearance from the U.S. FDA and is commercially available in Europe. VIVO is designed to provide an innovative cost-effective solution for improving the treatment of cardiac arrhythmias among other company topics.
This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chief Executive Officer in real time. Individual and institutional investors, as well as advisors and analysts, are invited to attend its real-time, interactive presentation at the Emerging Growth Conference.
David Jenkins, CEO will give a presentation and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and he will do his best to get through as many of them as possible.
Catheter Precision, Inc. (NYSE American:VTAK) will be presenting at 11:25am Eastern time for 30 minutes.
Please register here to ensure you can attend the conference and receive any updates that are released.
https://emerginggrowth.com/emerging-growth-conference-65/
If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, https://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.
https://www.accesswire.com/813088/catheter-precision-inc-nyse-americanvtak-presenting-at-the-emerging-growth-conference-on-december-6-2023